US ▾
Build an Inve Case for PAHC →

Phibro Animal Health (PAHC) earnings

Phibro Animal Health earnings: last reported Thu, 27 Aug 2026, for the quarter ended Jun 2026.

Phibro Animal Health earnings calls

Phibro Animal Health earnings calls (PAHC)

Latest concall · Q2 2026 · call held 27 Aug 2026

Phibro Animal Health Corporation Q4 FY26 — Record Sales and Strong EBITDA Growth

What went well

  • Achieved record net sales of more than $1.5 billion for fiscal year 2026.
  • Adjusted EBITDA increased 39% to $255 million for fiscal year 2026.
  • Fourth quarter sales grew 5% and adjusted EBITDA grew 29%.

What to watch

  • New MFA portfolio sales decreased 11% in Q4 due to a difficult prior-year comparison.
  • Regulatory uncertainty for Virginia Myosin in Brazil, with only minimal contribution assumed in FY27 guidance (FY26 sales of $27 million in Brazil).
Read the full call →

Performance −8.7% 1Y

$30.0$40.0$50.0$60.0Sept 25Nov 25Dec 25Feb 26Mar 26May 26Jun 26Aug 26Sept 26Q2 2026 — 27 Aug 2026

1Y: $39.15 on 29 Sept 2025 → $35.74. High $59.58 (13 Apr 2026), low $28.52 (2 Jun 2026).

Quarterly results

Q2 FY26: revenue up 4.8%, net profit up 26.0% against the same quarter last year.

US$ mn · quarterly
Line itemQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue260 309 348 379 364 +40%374 +21%384 +10%397 +5%
EBITDA18 26 34 34 51 +190%50 +97%45 +33%48 +43%
Net profit7 3 21 17 27 +280%27 +762%24 +15%22 +26%
How to read this

US$ million, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Balance sheet

Year endingJun 2021Jun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Reserves$218.01M$247.75M$260.91M$243.89M$272.70M$352.96M
Total liabilities$602.80M$669.26M$688.89M$725.54M$1.08B$1.12B
Fixed assets$154.71M$165.49M$195.57M$203.30M$354.69M$369.17M
Investments$43.00M$17.00M$40.00M$44.00M$9.00M$20.57M
Total assets$841.33M$931.70M$971.40M$982.18M$1.36B$1.50B
How to read this

As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Insider filings

145 filings between Oct 17, 2025 and Aug 6, 2026.

Open market

decisions to buy or sell

Purchases

$317.7K

1 purchase by 1 insider

Sales

$30.03M

117 sales by 1 insider

100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day

Compensation

not trading decisions
8
Award — granted as compensation
1
Option exercise — converted options into shares

Also filed: 11 conversions, 7 other filings.

Who traded

open market only
InsiderBoughtSoldLast filing
BENDHEIM JACK—$30.03MMay 7, 2026
CORCORAN E THOMAS$317.7K—May 29, 2026
Latest filings (50)
DateInsiderWhatSharesValue
Aug 6, 2026David Glenn Chief Financial OfficerAward 3,482$0
Aug 6, 2026Miller Larry Lee Chief Operating OfficerAward 3,726$0
Aug 6, 2026Rodriguez Patrick VP Finance and TreasurerAward 1,503$0
Aug 6, 2026BENDHEIM JACK Executive ChairmanAward 12,103$0
Aug 6, 2026Bendheim Daniel M President and CEOAward 11,699$0
Aug 6, 2026BENDHEIM Jonathan DirectorAward 2,716$0
Aug 6, 2026Escudero Lisa Ann See RemarksAward 1,547$0
Aug 6, 2026Weinstein Judith See RemarksAward 2,478$0
Aug 4, 2026Bendheim Daniel M President and CEOOther 486$17.8K
Aug 4, 2026BENDHEIM JACK Executive ChairmanOther 2,303$84.3K
Aug 4, 2026Escudero Lisa Ann See RemarksOther 265$9.7K
Aug 4, 2026Miller Larry Lee Chief Operating OfficerOther 635$23.2K
Aug 4, 2026Weinstein Judith See RemarksOther 472$17.3K
Aug 4, 2026David Glenn Chief Financial OfficerOther 840$30.7K
May 29, 2026CORCORAN E THOMAS DirectorPurchase 10,000$317.7K
May 7, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan2,029$99.8K
May 7, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,149$55.5K
May 7, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,350$64.2K
May 6, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan5,634$322.1K
May 6, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,406$81.7K
May 5, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan776$43.7K
May 5, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,264$349.1K
Apr 30, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,235$65.8K
Apr 30, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan5,805$305.6K
Apr 29, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan4,002$210.9K
Apr 29, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan3,038$161.6K
Apr 28, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,652$91.0K
Apr 28, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan797$45.2K
Apr 28, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan4,591$257.4K
Apr 23, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,619$357.9K
Apr 23, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan421$23.0K
Apr 22, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan7,040$382.2K
Apr 21, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan5,415$304.1K
Apr 21, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,625$89.9K
Apr 16, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan1,850$101.5K
Apr 16, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan5,190$283.1K
Apr 16, 2026BENDHEIM JACK President and CEOConversion 10b5-1 plan100,000$0
Apr 15, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan799$46.4K
Apr 15, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan3,618$207.0K
Apr 15, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan2,623$147.6K
Apr 14, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan492$29.4K
Apr 14, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,548$386.6K
Mar 31, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,609$356.0K
Mar 31, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan431$23.4K
Mar 30, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan617$33.5K
Mar 30, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,423$343.9K
Mar 26, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan6,760$383.9K
Mar 26, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan280$16.0K
Mar 25, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan552$31.4K
Mar 25, 2026BENDHEIM JACK President and CEOSale 10b5-1 plan4,916$275.3K

Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.